Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development.

Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development.

Item
http://www.wikidata.org/entity/Q33374478
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical useEfficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center ExperienceMeningococcal disease and the complement system.Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasmaDoes binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.A comparison of methods of pathogen inactivation of FFP.Therapeutic plasma proteins--application of proteomics in process optimization, validation, and analysis of the final product.Solvent/detergent plasma: pharmaceutical characteristics and clinical experience.Solvent/detergent-treated plasma: a tale of 30 years of experience.Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteers.Two approaches to the clinical dilemma of treating TTP with therapeutic plasma exchange in patients with a history of anaphylactic reactions to plasma.
P2860

Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development.

Item
http://www.wikidata.org/entity/Q33374478
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Normal levels of ADAMTS13 and ...... asma (Uniplas) in development.
@ast
Normal levels of ADAMTS13 and ...... asma (Uniplas) in development.
@en
type
label
Normal levels of ADAMTS13 and ...... asma (Uniplas) in development.
@ast
Normal levels of ADAMTS13 and ...... asma (Uniplas) in development.
@en
prefLabel
Normal levels of ADAMTS13 and ...... asma (Uniplas) in development.
@ast
Normal levels of ADAMTS13 and ...... asma (Uniplas) in development.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Normal levels of ADAMTS13 and ...... asma (Uniplas) in development.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1423-0410.2006.00884.X
P433
P478
P577
P698